Welcome to our dedicated page for Ellomay Cap SEC filings (Ticker: ELLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ellomay Capital’s disclosures can feel like decoding three utilities at once—Spanish solar plants, Israeli pumped-hydro construction, and Dorad’s gas-fired results all appear in one set of SEC documents. If tracking net-metering revenue or cross-border currency hedges sounds daunting, you’re not alone. Stock Titan surfaces the answers buried in those pages, so you spend minutes—not hours—finding what matters.
Our AI scans every new filing the moment it hits EDGAR and delivers concise, plain-English summaries. Need to monitor Ellomay Capital insider trading Form 4 transactions or compare cash-flow swings across quarters? We tag each data point and alert you as soon as a director buys or sells. The platform covers every form, including:
- 10-K: Get the Ellomay Capital annual report 10-K simplified with segment EBITDA, PPA schedules, and plant-capacity tables distilled into one dashboard.
- 10-Q: The latest Ellomay Capital quarterly earnings report 10-Q filing arrives with waterfall charts and variance commentary.
- 8-K: Material events—project milestones, turbine orders, covenant updates—are delivered as Ellomay Capital 8-K material events explained.
- Form 4: Follow Ellomay Capital Form 4 insider transactions real-time and spot patterns in Ellomay Capital executive stock transactions Form 4.
- DEF 14A: Review the Ellomay Capital proxy statement executive compensation without wading through legal boilerplate.
Whether you’re searching for “Ellomay Capital SEC filings explained simply” or want deeper Ellomay Capital earnings report filing analysis, Stock Titan’s algorithms translate footnotes into insights. Start understanding Ellomay Capital SEC documents with AI today and follow every solar watt, hydro megawatt-hour, and insider trade in real time.
Clal Insurance Enterprises Holdings Ltd filed an amendment to Schedule 13G reporting beneficial ownership of 1,940,045 ordinary shares of Ellomay Capital Ltd, equal to 14.58% of the class based on 12,852,585 shares outstanding as of June 30, 2025 (per the issuers Prospectus Supplement filed July 1, 2025). The filing reports shared voting and dispositive power of 1,940,045 shares.
Of the total, 41,204 shares (including 34,596 warrants exercisable within 60 days) are held for Clals own account ("Nostro Shares") and 1,898,841 shares (including 416,001 warrants exercisable within 60 days) are held for public clients through subsidiaries that operate under independent management and make independent voting and investment decisions. The filing includes a certification that the securities were not acquired to change or influence control. Signatures are dated 08/14/2025.
Menora Mivtachim Holdings Ltd., together with its subsidiary Menora Mivtachim Pensions & Gemel Ltd., filed a Schedule 13G reporting a passive, >5% position in Ellomay Capital Ltd. (ELLO).
The parent company discloses 972,346 ordinary shares, equal to 7.06 % of Ellomay’s 13,778,585 shares outstanding as of 28 Jul 2025. The pension subsidiary separately holds 856,779 shares (6.22 %). All voting and dispositive powers are shared; neither entity claims sole power over the shares and both expressly disclaim any intent to influence control of the issuer.
The stake is aggregated across several wholly- or majority-owned insurance, pension and portfolio-management units, with economic benefits ultimately accruing to policy-holders and fund members. The filing was signed 3 Aug 2025 by CFO Ran Kalmi and authorised signatory Lior Yochpaz and includes a joint-filing agreement as Exhibit 1.
Ellomay Capital Ltd. (ELLO) reports a key milestone in its plan to enlarge its position in Dorad Energy Ltd. On 10 July 2025 Dorad’s board approved the transfer of 7.5 % of Dorad’s outstanding shares to Ellomay’s wholly owned subsidiary, Ellomay Luzon Energy Infrastructures Ltd., and a separate transfer of 10 % to The Phoenix Insurance Company Ltd. The approval formally validates Ellomay’s previously exercised right of first refusal.
- The sole remaining closing condition for Ellomay’s initial 7.5 % purchase is the consummation of Phoenix’s 10 % acquisition, a step that is outside Ellomay’s control.
- Ellomay has reserved the right to acquire an additional 7.5 % should a parallel purchase by Edelcom Ltd. fail to close.
- No purchase price, financing structure or earnings impact was disclosed in the filing.
Management cannot currently estimate when—or if—the closing condition will be satisfied. The filing reiterates extensive forward-looking-statement caveats concerning regulatory approvals, market conditions, geopolitical risks and other uncertainties in Israel, Spain, Italy and the U.S.
FAQ
What is the current stock price of Ellomay Cap (ELLO)?
What is the market cap of Ellomay Cap (ELLO)?
